UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Achmea Investment Management B.V.

Achmea Investment Management B.V. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 75,870 shares of the healthcare conglomerate’s stock after selling 6,708 shares during the period. Achmea Investment Management B.V.’s holdings in UnitedHealth Group were worth $38,380,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter worth about $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter worth about $30,000. Promus Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group in the third quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 1.0 %

UnitedHealth Group stock opened at $481.18 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market cap of $440.14 billion, a price-to-earnings ratio of 31.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm’s 50 day moving average price is $512.33 and its two-hundred day moving average price is $551.50.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the company posted $5.83 EPS. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.75%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.